BWAY
BrainsWay Ltd.
NASDAQ · ILHealthcareMedical - Devices
$16.50+4.90%
Price as of Jul 20, 2026
BWAY financials
BrainsWay Ltd. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $52.2M | $41.0M | $31.8M | $27.2M |
| Cost of revenue | $12.8M | $10.4M | $8.3M | $7.1M |
| Gross profit | $39.4M | $30.6M | $23.5M | $20.0M |
| Operating expenses | $35.1M | $29.2M | $28.4M | $32.7M |
| Operating income | $4.3M | $1.4M | -$5.0M | -$12.7M |
| Net income | $7.6M | $2.9M | -$4.2M | -$13.3M |
| EBITDA | $11.5M | $5.4M | -$2.6M | -$11.5M |
| Basic EPS | $0.40 | $0.09 | $-0.13 | $-0.43 |
| Diluted EPS | $0.36 | $0.09 | $-0.13 | $-0.43 |
| Balance sheet | ||||
| Cash & equivalents | $67.7M | $69.3M | $10.5M | $47.6M |
| Total assets | $112.9M | $94.3M | $63.0M | $64.5M |
| Total liabilities | $39.7M | $32.0M | $21.4M | $19.1M |
| Stockholders’ equity | $73.2M | $62.3M | $41.6M | $45.4M |
| Total debt | $6.8M | $5.6M | $471.0K | $488.0K |
| Net debt | -$60.9M | -$63.7M | -$10.0M | -$47.1M |
| Cash flow | ||||
| Operating cash flow | $18.2M | $10.3M | $1.3M | -$9.8M |
| Capital expenditure | -$1.8M | -$3.8M | -$2.4M | $9.7M |
| Free cash flow | $16.4M | $6.5M | -$1.1M | -$9.8M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | -$52.0K |